Table 3.

Prevalence (%) of Variants Based on the Carboxy Terminus of LMP-1 by Clinical Condition and Geographic Region

Clinical Condition	LMP-1 Genotype	Asia	Africa	North America	Europe
NPC	China 1	82.5%		66.0%	0.0%
	China 2	9.7%		0.0%	0.0%
	China 3	9.0%		0.0%	0.0%
	Med	0.0%		0.0%	89.0%
	Alaskan	0.0%		33.0%	0.0%
	NC	0.0%		0.0%	0.0%
	B95-8	5.1%		0.0%	11.0%
	Other	1.8%a		0.0%	0.0%
total cases		217	0	3	9
BL	China 1		0.0%	0.0%
	China 2		0.0%	0.0%
	China 3		0.0%	0.0%
	Med		100.0%	100.0%
	Alaskan		0.0%	0.0%
	NC		0.0%	0.0%
	B95-8		0.0%	0.0%
total cases		0	1	1	0
HL	China 1	100.0%			56.0%
	China 2	0.0%			0.0%
	China 3	0.0%			0.0%
	Med	0.0%			12.0%
	Alaskan	0.0%			0.0%
	NC	0.0%			3.0%
	B95-8	0.0%			29.0%
total cases		1	0	0	34
Nonmalignant/healthy	China 1	70.0%		33.0%	27.0%
	China 2	0.0%		0.0%	0.0%
	China 3	0.0%		0.0%	0.0%
	Med	13.3%		33.0%	12.0%
	Alaskan	0.0%		0.0%	0.0%
	NC	0.0%		0.0%	18.0%
	B95-8	10.0%		33.0%	42.0%
	Other	6.7%a		0.0%	0.0%
total cases		60	0	3	33

(Edwards et al., 1999; Saechan et al., 2006; Tiwawech et al., 2008)